Protective Effect of Vitamin E against Moxifloxacin Induced Side Effect in Rats

Abstract

Moxifloxacin is a fourth-generation of fluoroquinolone antimicrobial, (at first called BAY 12-8039) and it is advertised worldwide under the brand name avelox. Moxifloxacin is active against both Gram-positive and Gram-negative bacteria. The moxifloxacin is a promising new agent that may have added to existing antituberculotic agents by evaluating the action of moxifloxacin in tuberculosis treatment (Minov et al., 2018). Fluoroquinolones (Moxifloxacin and Ciprofloxacin) cause arthrotoxicity in adolescent individuals and related with reversible musculoskeletal disorders in the youngsters